@ClareLou9

Yue Clare Lou, Ph.D., is a pioneering entrepreneur and the founder of Sift Biosciences, a biotech company focused on developing T-cell modulators for cancer treatment. Leveraging advanced technologies such as artificial intelligence, metagenomics, and high-throughput immune profiling, Clare aims to revolutionize cancer therapy and improve patient outcomes. With a strong background in immunology and biotechnology, Clare is dedicated to pushing the boundaries of science to create innovative solutions for complex health challenges.